FI962355L - Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen - Google Patents

Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen Download PDF

Info

Publication number
FI962355L
FI962355L FI962355A FI962355A FI962355L FI 962355 L FI962355 L FI 962355L FI 962355 A FI962355 A FI 962355A FI 962355 A FI962355 A FI 962355A FI 962355 L FI962355 L FI 962355L
Authority
FI
Finland
Prior art keywords
drug
treatment
respiratory distress
distress syndrome
synthetic peptides
Prior art date
Application number
FI962355A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962355A0 (fi
FI962355A7 (fi
Inventor
Tsunetomo Takei
Eiji Ohtsubo
Hirosi Ohkawa
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of FI962355A0 publication Critical patent/FI962355A0/fi
Publication of FI962355A7 publication Critical patent/FI962355A7/fi
Publication of FI962355L publication Critical patent/FI962355L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
FI962355A 1993-12-08 1994-12-07 Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen FI962355L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30765793 1993-12-08
PCT/JP1994/002057 WO1995015980A1 (en) 1993-12-08 1994-12-07 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome

Publications (3)

Publication Number Publication Date
FI962355A0 FI962355A0 (fi) 1996-06-06
FI962355A7 FI962355A7 (fi) 1996-06-06
FI962355L true FI962355L (fi) 1996-06-06

Family

ID=17971685

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962355A FI962355L (fi) 1993-12-08 1994-12-07 Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen

Country Status (22)

Country Link
US (1) US5827825A (cs)
EP (1) EP0733645B1 (cs)
JP (1) JP3644035B2 (cs)
KR (1) KR100342806B1 (cs)
CN (1) CN1057099C (cs)
AT (1) ATE234865T1 (cs)
AU (1) AU682738B2 (cs)
BG (1) BG62777B1 (cs)
CA (1) CA2178345A1 (cs)
CZ (1) CZ162396A3 (cs)
DE (1) DE69432313T2 (cs)
DK (1) DK0733645T3 (cs)
ES (1) ES2189825T3 (cs)
FI (1) FI962355L (cs)
HU (1) HU215933B (cs)
NO (1) NO962403L (cs)
NZ (1) NZ277095A (cs)
PL (1) PL180020B1 (cs)
PT (1) PT733645E (cs)
RO (1) RO118298B1 (cs)
SK (1) SK71496A3 (cs)
WO (1) WO1995015980A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017872A1 (en) * 1994-12-07 1996-06-13 Tokyo Tanabe Company Limited Intermediate for producing surfactant peptide
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
JPH11217397A (ja) * 1997-11-27 1999-08-10 Saburo Aimoto ペプチドチオールエステルの製造方法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
BR9906091A (pt) * 1999-12-22 2002-06-04 Conselho Nacional Cnpq Usos de resina de troca aniÈnica (epm-7) como suporte sólido para a sìntese peptìdica e para cromatografia de afinidade
US6998384B2 (en) 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ATE376556T1 (de) * 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
AU2005247319B2 (en) * 2004-04-28 2011-12-01 Molecules For Health, Inc. Methods for treating or preventing restenosis and other vascular proliferative disorders
JPWO2005105111A1 (ja) * 2004-04-29 2008-07-31 相男 李 人工肺サーファクタント組成物およびその使用方法
KR100635541B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
EP2298349A1 (en) 2005-01-06 2011-03-23 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
WO2008036293A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
JP5473899B2 (ja) 2008-04-02 2014-04-16 国立大学法人徳島大学 合成ペプチドを含有する抗原薬物ビークルとこれを用いる粘膜ワクチン
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290516A4 (en) * 1986-10-24 1989-11-14 Jeffrey A Whitsett PROTEINS RELATED TO SURFACE-EFFECTIVE HYDROPHOBIC LUNG ACTIVE SUBSTANCES.
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
CA2178345A1 (en) 1995-06-15
NZ277095A (en) 1997-09-22
SK71496A3 (en) 1996-11-06
KR960706507A (ko) 1996-12-09
JP3644035B2 (ja) 2005-04-27
US5827825A (en) 1998-10-27
RO118298B1 (ro) 2003-04-30
EP0733645A1 (en) 1996-09-25
HUT74880A (en) 1997-02-28
FI962355A0 (fi) 1996-06-06
PL180020B1 (en) 2000-12-29
PT733645E (pt) 2003-07-31
DE69432313T2 (de) 2003-10-16
FI962355A7 (fi) 1996-06-06
HU215933B (hu) 1999-03-29
CZ162396A3 (en) 1996-10-16
AU682738B2 (en) 1997-10-16
BG62777B1 (bg) 2000-07-31
NO962403D0 (no) 1996-06-07
KR100342806B1 (ko) 2002-11-29
ES2189825T3 (es) 2003-07-16
AU1199295A (en) 1995-06-27
DK0733645T3 (da) 2003-07-14
CN1136813A (zh) 1996-11-27
NO962403L (no) 1996-06-07
DE69432313D1 (de) 2003-04-24
PL314872A1 (en) 1996-09-30
ATE234865T1 (de) 2003-04-15
WO1995015980A1 (en) 1995-06-15
EP0733645B1 (en) 2003-03-19
CN1057099C (zh) 2000-10-04
HU9601563D0 (en) 1996-08-28
BG100554A (bg) 1996-12-31
EP0733645A4 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
FI962355A7 (fi) Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivin en aine ja lääke hengityselinsairausoireyhtymän hoitamiseen
FI961219A7 (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
DE59000161D1 (de) Atemschutzmaske.
DE69433762D1 (de) Vereinfachte herunterfallende Beatmungsmaske
FI944170A7 (fi) Typpioksidia ilmasta lääketieteellisiin käyttötarkoituksiin
FI945281A7 (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
IT1267448B1 (it) Vaccino per la prevenzione della sindrome riproduttiva e respiratoria porcina.
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
FI940810L (fi) Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI954111L (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO904877D0 (no) Fremgangsmaate for fremstilling av titandioxyd.
EE9400326A (et) Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
IT8947598A0 (it) Composti carbonilati, loro preparazione e loro impiego come erbicidi
FI961938L (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO306347B1 (no) Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne
NO308527B1 (no) Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
NO893062D0 (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
FI934680A7 (fi) Aryylimorfoliini, valmistus ja käyttö
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
IT1240374B (it) Composti polifluoroalchilici azotati, procedimento per la loro preparazione e loro impiego
NO894532D0 (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
AU3905693A (en) Synthetic peptide, pulmonary surfactant containing the same, and remedy for respiratory distress syndrome
ATA30594A (de) Gereinigte form von streptograminen, ihre herstellung und sie enthaltende pharmazeutische massen
GB2316681B (en) Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
ITMI913466A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fluoroetano e dell'1.1.1-trifuoro-2,2-diocloroetano